Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Shigella Sonnei OSPC-rDT Conjugate Vaccine

NCT01399424 is registered in ClinicalTrials.gov with Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) as lead sponsor.

NCT NCT01399424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01399424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Shigella Sonnei OSPC-rDT Conjugate Vaccine
Lead sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Phase
Phase 1
Overall status
Withdrawn
Start date
July 16, 2011
Completion date
April 25, 2012
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

shigellosis